0
Upcoming Allied Market Research
2022
Megalencephaly-polymicrogyria-polydactyly-hydrocephalus Syndrome Market

Megalencephaly-polymicrogyria-polydactyly-hydrocephalus Syndrome Market

By Symptom (Polymicrogyria, Megalencephaly, Intellectual Disability, Seizures, Polydactyly, and Hydrocephalus), Treatment (Neurosurgery, Genetic Therapy, Drugs, and Others), End User (Hospitals & Clinics, Surgical Centers, Diagnostic Centers, and Others), and Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Others): Global Opportunity Analysis and Industry Forecast, 2021-2028

Report Code: A11443
Pages: NA
Nov 2022 | 712 Views
Author(s) : Onkar S
Tables: NA
Charts: NA
  • Formats*:

  • Single User License, Five User
    License & Enterprise User License

  • Data Pack Excel License

  • It comes with the additional cost
    of $2500.00 contact sales.

 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Megalencephaly-polymicrogyria-polydactyly-hydrocephalus Syndrome Market

Request Now !

Megalencephaly-polymicrogyria-polydactyly-hydrocephalus (MPPH) syndrome is a rare disorder that affects the brain development. Affected individuals are born with megalencephaly (a large brain and head size). The brain and head continue to grow quite rapidly in the first two years of the patient’s life. In addition, the MPPH syndrome is associated with bilateral perisylvian polymicrogyria, which is a brain abnormality. The surface of the brain has many folds and ridges, called gyri. The problems with brain development cause a variety of neurological signs and symptoms. Individuals suffering from this syndrome have an intellectual disability and delayed development of the body. Moreover, they face difficulty in coordinating the mouth movements and tongue (known as oromotor dysfunction).

COVID-19 Impact Analysis

COVID-19 is an infectious disease that originated in the Hubei province of the Wuhan city in China in late December. The highly contagious disease, caused by a virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is transmitted from human to human. Since the outbreak in December 2019, the disease has spread to almost 213 countries around the globe with the World Health Organization declaring it a public health emergency on March 11, 2020.

Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicine supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as hydroxychloroquine have witnessed a dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunities for manufacturers of COVID-19 management drugs, as many developed countries are facing a shortage of these drugs. Thus, the pharmaceutical and biotechnology industry industries are expected to witness significant growth in the future, owing to the demand for vaccines and treatment drugs for COVID-19. This, in turn, is expected to have a significant impact on the megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome market.

Top Impacting Factors

Rise in multiple birth defect cases that cause MPPH syndrome and surge in prevalence of developmental delay across the globe are the major factors that drive the growth of the global megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome market.

Moreover, alarming increase in incidence of nerve disorders among infants and surge in the cases of gene expression changes that occur due to chemical modification in the fetus’ DNA accelerate the growth of the market. Furthermore, upsurge in R&D activities by biotechnology and pharmaceutical companies with the purpose of improving the treatment for MPPH syndrome further influence the market.

In addition, increase in awareness regarding MPPH, developing healthcare infrastructure, rise in funds for R&D, and surge in healthcare expenditure positively affect the megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome market.

However, the population is less open to therapies that target treatment in infants from the embryonic stage, which hamper the growth of the market growth during the forecast period. High cost associated with the treatment of this syndrome further hamper the market growth during the study period.

Market Trends

Many pharmaceutical companies such as Ionis Pharmaceuticals and Novo Nordisk A/S are now delivering low-cost personalized products to patients on account of emerging developments in the healthcare sector, leading to rising customer expectations.

Various companies are focusing on organic growth strategies, which include product approvals, product launches, and others such as events and patents. Inorganic growth strategies that are witnessed in the market include partnership & collaborations and acquisitions.

The key market players for the megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome are focusing on portals that are dedicated to rare diseases and orphan drugs. Orphan drugs are rare drugs for rare disorders. These drugs are not profitable to produce without financial assistance from the government or other external sources.

Key Benefits of the Report

  • This study presents the analytical depiction of the megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome industry along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with a detailed analysis of the market share.
  • The current market is quantitatively analyzed from 2020 to 2028 to highlight the megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
  • The report provides a detailed market analysis depending on competitive intensity and how the competition will take shape in the coming years

Questions Answered in the Global megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome Market Report

  • Which are the leading players active in the megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome market?
  • How is each segment of the market expected to grow during 2021–2028?
  • What are the adoption trends for megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome in emerging economies and established economies across the world?
  • What are the current trends that will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities of the market?
  • What future projections would help in taking further strategic steps?
  • What is megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome?
  • What is megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome market prediction in the future?
  • What are the current trends and predicted trends?

Megalencephaly-polymicrogyria-polydactyly-hydrocephalus Syndrome Market Report Highlights

Aspects Details
Symptoms
  • Polymicrogyria
  • Megalencephaly
  • Intellectual Disability
  • Seizures
  • Polydactyly
  • Hydrocephalus
By Treatment
  • Neurosurgery
  • Genetic Therapy
  • Drugs
  • Others
End-Users
  • Hospitals and Clinics
  • Surgical Centers
  • Diagnostic Centers
  • Others
By DISTRIBUTION CHANNEL
  • Hospital Pharmacy
  • Retail Pharmacy
  • Others
By REGION
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA
Key Market Players Novartis AG, F. Hoffmann-La Roche Ltd., Boehringer Ingelheim International GmbH., Pfizer Inc., Ionis Pharmaceuticals, Abbott, Novo Nordisk A/S, Takeda Pharmaceutical Company Limited.,, AstraZeneca, CYTOKINETICS, INC., Regeneron Pharmaceuticals Inc., Salarius Pharmaceuticals, Inc., Leadiant Biosciences, Inc., PTC Therapeutics., Natera, Catalyst Pharmaceuticals, Inc.
 

Loading Table Of Content...


 
 
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.
PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : + 44-845-528-1300
Email : help@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Enquiry Now
RELATED TAGS

Purchase Full Report of
Megalencephaly-polymicrogyria-polydactyly-hydrocephalus Syndrome Market

Start reading.
This Report and over 19,311+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,690
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Single User
  • $5,820
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Five Users
  • $6,540
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Enterprise
    License/PDF

  • $9,870
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Library
    Membership

  • $ 999
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

RELATED REPORTS
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers